Character Bio
The Research Associate/Senior Research Associate (Glaucoma) at Character Biosciences will develop in vitro disease models and conduct cell-based assays to explore target biology and assess potential therapeutics. Responsibilities include engineering and maintaining iPSC-derived human neurons and glia, executing functional assays, troubleshooting experiments, and collaborating with team members across projects. The position requires 3+ years of research experience in neurobiology or a related field, with a focus on mammalian cell culture and assay development in an on-site laboratory setting.
Headquarters
San Francisco, California, United States
Company Size
11-50 employees
Founded
2019
Character Bio is a precision medicine company focused on revolutionizing the treatment of polygenic diseases, with an initial emphasis on age-related macular degeneration (AMD). By leveraging human genetics and large genomic databases, Character Bio aims to uncover the genetic drivers of disease progression, enabling the development of targeted therapies that personalize treatment for patients. Their mission is to transform eye care by integrating clinical data, imaging, and advanced analytical methodologies to understand and combat progressive eye diseases effectively.
Fierce Biotech Names Character Biosciences a "Fierce 15" Biotech Company of 2025
Sep 22, 2025
Character Biosciences Raises $93 Million Series B to Advance Precision Medicine for Progressive Eye Diseases
Mar 25, 2025
Hop In to Learn Everything You Need to Know About Lincoln Lawyer’s Izzy Letts
1 month ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Character Bio.
Character Bio didn’t post a salary, so this is our estimate from similar listings.
Character Biosciences Expands Leadership Team with Key Appointments and Announces Series B Extension
Sep 17, 2025
Research Associate I/II
Lexeo Therapeutics
Scientist 3/4, Complex in Vitro Systems
Genentech
Director of In Vitro Pharmacology
Eli Lilly and Company
Research Associate (Contractor), Cell Therapy
Obsidian Therapeutics
Associate Scientist - Cellular Assay Development, Functional Genomics
Amgen
Senior Scientist – Assay Biology
Syngene International Limited